Beta-adrenergically mediated thermogenic and heart rate responses: effect of obesity and weight loss.
beta-Adrenergically mediated thermogenic and heart rate (HR) responses, as assessed by stepwise intravenous infusion of the beta-agonist isoprenaline (ISO), were evaluated by partial regression analysis in a group of men with a wide range of body fat (n = 30) and in a subgroup of 16 obese men after weight loss. beta-Adrenergically mediated thermogenesis (open-circuit ventilated-hood system) was blunted in obese subjects, as reflected by a significant positive correlation between percent body fat (hydrostatic weighing) and the plasma ISO concentration needed to increase resting energy expenditure (EE) by 15% (P < .001). The magnitude of the beta-adrenergically mediated HR response was (negatively) associated with the basal plasma norepinephrine (NE) concentration (P < .001). Weight reduction resulted in a significant increase in thermogenic and HR responses in obese subjects. Furthermore, the increase in thermogenic response as a result of weight loss was negatively related to the magnitude of thermogenic response (P < .01) and positively related to the initial percent body fat (P < .05). The increase in HR response as a result of weight loss was positively related to the decrease in basal NE (P < .01) and the change in percent body fat (P < .05). In conclusion, the degree of adiposity was shown to be negatively related to the magnitude of beta-adrenergically mediated thermogenesis, whereas the HR response was merely related to basal NE. Since weight loss resulted in a significant increase in the thermogenic response, the blunted beta-adrenergically mediated thermogenesis does not seem to be a primary factor contributing to the development of obesity.
Blaak
E E
EE
Department of Human Biology, University of Limburg, Maastricht, The Netherlands.
van Baak
M A
MA
Kester
A D
AD
Saris
W H
WH
D000328:Adult; D001833:Body Temperature Regulation / Q000187:drug effects / Q000502:physiology*; D004734:Energy Metabolism / Q000187:drug effects; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000097:blood; D009765:Obesity / Q000473:pathology* / Q000503:physiopathology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D015431:Weight Loss
D011943:Receptors, Adrenergic, beta; D007545:Isoproterenol; D009638:Norepinephrine